Mehran Alizadeh Aghdam

AGIKO

Strategic program(s):

Contact

Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedema Mehran Alizadeh Aghdam, Zonne L.M. Hofman, Michelle Meertens, Ans Lebens, C. Erik Hack, André C. Knulst, Coen Maas, Heike Röckmann
Allergy: European Journal of Allergy and Clinical Immunology, 2022, vol. 77, p.3673-3676

Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients Coco Dekkers, Mehran Alizadeh Aghdam, Marlies de Graaf, André C Knulst, Yolanda Meijer, Juul M P A van den Reek, Marike B Stadermann, Heike Röckmann
Pediatric Allergy and Immunology, 2021, vol. 32, p.720-726

Systemic and local evidence for complement involvement in chronic spontaneous urticaria Mehran Alizadeh Aghdam, Mignon van den Elzen, Harmieke van Os-Medendorp, Marijke R van Dijk, Edward F Knol, André C Knulst, Heike Röckmann, Henny G Otten
Clinical and Translational Allergy, 2021, vol. 11, p.1-8

Effective omalizumab interval prolongation in the treatment of chronic urticaria Mehran Alizadeh Aghdam, Rianne Henriëtte Pieterse, Petra Adriana Kentie, Feiko Rijken, André Cornelis Knulst, Heike Röckmann
Journal of Allergy and Clinical Immunology: In Practice, 2020, vol. 8, p.3667-3668.e1

Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria M Alizadeh Aghdam, E F Knol, M van den Elzen, C den Hartog Jager, H van Os-Medendorp, A C Knulst, H G Otten, H Röckmann
Clinical and Experimental Allergy, 2020, vol. 50, p.364-371